Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Neuroone Medical Technologies Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 19 | 19 | 0 |
| Shares | 4.30M | 3.69M | −611.5K (−14.2%) |
| Value | $5.16M | $2.95M | −$2.21M (−42.8%) |
New holders (4)
Institutions that held Neuroone Medical Technologies Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 19,149 | $15.0K | 0.00% |
| Raymond James & Associates | 17,400 | $13.9K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,400 | $8.00K | 0.00% |
| Bank of America Corp | 216 | $173 | 0.00% |
Sold out (4)
Institutions that held Neuroone Medical Technologies Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 11,310 | $13.6K |
| Centerpoint Advisors, LLC | 5,000 | $6.00K |
| Simplex Trading, LLC | 1,720 | $2.00K |
| Wells Fargo & Company | 193 | $232 |